Skip to content
Review Open access

Joint disease in systemic lupus erythematosus: clinical manifestations, immunopathology, and treatment

Oct 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 116 references
Medicine

TL;DR

It is argued that single-cell interrogation of the lupus synovium, a lupus-specific imaging scoring system and a validated imaging-anchored articular outcome measure are the necessary next steps if this manifestation is to be treated with the precision now applied to lupus nephritis.

Abstract

Joint involvement affects the majority of patients with systemic lupus erythematosus and is consistently ranked among the manifestations with the largest impact on daily function, yet lupus synovium remains one of the least interrogated major target tissues in this disease. The primary literature on lupus synovial tissue rests mainly on two datasets, neither generated by single-cell transcriptomic or mass cytometric methods, and what they describe is a relatively pauci-immune and myeloid-dominated compartment carrying an interferon-inducible transcriptional signature in situ, without the ectopic germinal centers and expanded pathogenic fibroblast populations that characterize rheumatoid synovitis. The cell populations now central to systemic lupus biology, among them T peripheral helper cells and double-negative 2 B cells, have never been examined in lupus synovial tissue, so that every cellular account of this compartment remains an extrapolation from rheumatoid arthritis. Recent large-cohort data nevertheless indicate that lupus arthropathy is not a single entity, since non-deforming arthritis and Jaccoud’s arthropathy are both associated with a high type I interferon signature whereas arthritis with clinically irreducible deformity is interferon-low, although whether these represent distinct biological trajectories or successive stages of a single process remains to be established. This heterogeneity is invisible to the instruments used in practice, because the composite indices that grade disease activity and determine eligibility for advanced therapy depend on the detection of joint swelling at the bedside, while musculoskeletal ultrasound and contrast-enhanced magnetic resonance imaging independently demonstrate inflammation in approximately half of patients whose joints appear clinically unremarkable, together with erosive change in patients who lack anti-citrullinated protein antibodies. Misclassification of articular disease is therefore systematic and bidirectional, and the same failure has propagated into drug development, where no recent registrational program has used imaging to define articular response, even though the proportion of patients failing on articular endpoints lies between roughly a third and a half. This review synthesizes the immunopathological, biomarker, imaging and therapeutic literatures, and argues that single-cell interrogation of the lupus synovium, a lupus-specific imaging scoring system and a validated imaging-anchored articular outcome measure are the necessary next steps if this manifestation is to be treated with the precision now applied to lupus nephritis.

Read PDF

Similar papers

Open access Oct 2026

Single-cell mass cytometry cartography highlights systemic lupus erythematosus and Sjögren’s disease immune differences

Objectives Autoimmune diseases such as primary Sjögren’s disease (pSjD) and systemic lupus erythematosus (SLE) share clinical and serological features, including type I interferon signatures, autoantibody formation, and chronic inflammation, but the underlying immunopathology is not the same. To support the development...

F. Szelinski, Ana-Luisa Stefanski, A. Wiedemann et al. · 0 citations
Review

World Journal of Clinical Pediatrics

This review examines the clinical spectrum of rheumatological manifestations associated with IEIs, encompassing arthritis, cytopenias, vasculitis, macrophage activation syndrome, systemic lupus erythematosus, inflammatory bowel disease phenotypes, polyautoimmunity, and autoimmune lung disease.

Abarna Thangaraj, Ridhima Aggarwal, Soumyadeep C. Sarkar et al. · 0 citations
Review Open access Sep 2026

SYSTEMIC LUPUS ERYTHEMATOSUS – PAST, PRESENT AND EMERGING THERAPIES

Background Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease characterized by immune dysregulation, autoantibody production, and immune complex-mediated tissue damage. Despite advances in disease management, SLE remains associated with substantial morbidity, increased mortality, and signif...

Jakub Zwardoń, Aleksandra Suchołbiak, Miłosz Rewekant et al. · 0 citations
Open access Oct 2026

Immunosuppressant-refractory Multifaceted Immune Dysregulations for Systemic Lupus Erythematosus.

While the systemic lupus erythematosus (SLE), a severe autoimmune disease, is known to relapse frequently after treatment, none of the previous single-cell studies have examined the immune dynamics and their potential contribution to this relapse in the real clinical setting. To address this issue, here we employed sin...

Chen-Rui Xia, J. Qian, Yang Ding et al. · 0 citations
Review Oct 2026

Childhood-Onset Systemic Lupus Erythematosus: Genetic Mechanisms and Therapeutic Strategies.

OBJECTIVE Childhood-onset systemic lupus erythematosus (cSLE) is more aggressive than adult SLE, with higher rates of lupus nephritis, organ damage, and early mortality. This review synthesizes recent advances in cSLE genetics and targeted therapies. METHODS We conducted a comprehensive literature search in PubMed an...

Yu-Xing Shi, Zai-Quan Shi, Li-Fang Zhang et al. · 0 citations
Review Open access Oct 2026

Single-cell Transcriptomics in Autoimmune Diseases: Mechanistic Insights, Cross-disease Convergence, and Translational Challenges in Rheumatoid Arthritis, Systemic Lupus Erythematosus, Type 1 Diabetes, and Multiple Sclerosis

Autoimmune diseases are characterized by loss of immune tolerance and substantial heterogeneity across patients, tissues, and disease stages. Although bulk transcriptomic studies have identified important inflammatory pathways, they cannot directly resolve rare, transitional, and tissue-contextualized cell states that...

T. Nguyen, T. Nguyễn, O. Hoang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.